The 10 Biggest Bottlenecks Slowing Drug Development

• August 4, 2026

Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn’s and Colitis (PREdiCCt) prospective cohort study

• by Nathan Constantine-Cooke, Beatriz Gros, Nikolas Plevris, Linda J Williams, Gareth-Rhys Jones, Janet Kyle, Nicholas A Kennedy, Victor Velasco-Pardo, Alexander Rudge, Debbie Alexander, Carl A Anderson, Maiara Brusco de Freitas, Lisa M Derr, Lauranne AAP Derikx, Sian Gilchrist, Paul Henderson, Graham W Horgan, Peter Irving, Christopher A Lamb, Luke Jostins-Dean, James O Lindsay, Jonathan MacDonald, Craig Mowat, Charles Murray, Miles Parkes, Spyros I Siakavellas, Catalina A Vallejos, Daniel R Gaya, Jonathan M Rhodes, Alexandra M Johnstone, Christopher J Weir, Charlie W Lees

• August 1, 2026

Evaluation of the frequency, risk factors and outcomes of ROP in preterm infants with a BW >1500 g or GA >32 weeks in Turkiye (TR-ROP 2) and medicolegal fears: a Turkish Neonatal Society multicentre study

• by Ahmet Yagmur Bas, Esin Koc, Sezin Unal, Ibrahim Murat Hirfanoglu

• August 1, 2026

QOL After Head and Neck Reconstruction

A prospective cohort study suggests that clinically meaningful quality‐of‐life changes continue well beyond the first postoperative year, with one‐year complications emerging as the strongest potentially modifiable predictor of later decline.

• by Andrea Surnit

• August 4, 2026

• 3 min